Europe Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Population Health), End User (Payer, Hospital, ASC) Market Size, Opportunities, Trends - Forecast to 2030

icon1
USD 50.91 BN
MARKET SIZE, 2030
icon2
CAGR 23.9%
(2025-2030)
icon3
300
REPORT PAGES
icon4
100
MARKET TABLES

OVERVIEW

europe-healthcare-analytics-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The Europe healthcare analytics market, valued at US$14.17 billion in 2024, stood at US$17.47 billion in 2025 and is projected to advance at a resilient CAGR of 23.9% from 2024 to 2030, culminating in a forecasted valuation of US$50.91 billion by the end of the period. The growth of the European healthcare analytics market is driven by the region’s rapid digital health transformation, characterized by the growing adoption of national EHR systems, effective GDPR-led data governance, and the increased use of Population Health management in response to rising numbers of chronic diseases and aging populations. It has witnessed increasing investments in AI-predictive analytics, real-time data integration, and interoperability policies, motivated, for example, by the EU's European Health Data Space (EHDS) initiative or the Hospital Future Act (KHZG) in Germany. This has driven the demand for analytics solutions that can better facilitate clinical decision-making, operational efficiency, and value-based healthcare delivery within the healthcare system in Europe.

KEY TAKEAWAYS

  • By Country
    In 2024, Germany accounted for 28.6% of revenue in the European healthcare analytics market.
  • By Component
    By component, the services segment registered the fastest CAGR of 24.3% during the forecast period.
  • By Type
    By type, the predictive analytics segment is projected to grow at the fastest rate from 2025 to 2030.
  • By Application
    By application, the financial analytics segment is expected to dominate the market with a market share of 33.9% in 2024.
  • By End user
    By end user, the providers segment is expected to grow the fastest during the forecast period.
  • Competitive Landscape
    Optum, McKesson Corporation, and Oracle were identified as some of the star players in the Europe healthcare analytics market, given their strong market share and product footprint.
  • Competitive Landscape
    Quibim and Owkin Inc., among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The healthcare analytics market in Europe is witnessing strong growth, driven by the rapid expansion of digital health ecosystems, widespread adoption of EHRs and AI-enabled decision-support tools, and increasing pressure to enhance care quality, cost efficiency, and population health outcomes. New deals and developments, such as hospital–technology provider partnerships for predictive analytics, national investments in interoperable data platforms aligned with the GDPR and the European Health Data Space (EHDS), and advancements in real-time analytics, automation, and cloud-based solutions, are reshaping the region’s healthcare analytics landscape.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact on consumers’ business in the Europe healthcare analytics market is shaped by emerging provider and payer dynamics and system-level drivers in the region, along with disruptions in the healthcare industry structure in the region, which influence the environment surrounding consumers’ business in the Europe healthcare analytics market. The major adopters of healthcare analytics solutions for improved clinical outcomes, population health management, and healthcare efficiency are hospitals and IDNs, payers and healthcare providers, as well as public health organizations. The adoption of AI-driven predictive analytics and real-time clinical intelligence platforms enables providers to shift from reporting to decision-making. This may also focus on shifting from reactive decision-making to value-based decision-making, facilitated by the advent of more secure data governance practices. The onset of GDPR and efforts for cross-border interoperability, as well as the demonstration of healthcare effectiveness, aim to achieve financial and clinical outcomes.

europe-healthcare-analytics-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Expansion of national digital health strategies
  • Rapid rise of telehealth and remotely monitored care models
RESTRAINTS
Impact
Level
  • High upfront cost of advanced analytics platforms and cloud-based infrastructure
  • Ongoing concerns related to cybersecurity and data breaches in critical health systems
OPPORTUNITIES
Impact
Level
  • Push toward value-based care for outcome-based analytics
  • Significant expansion of national patient registries
CHALLENGES
Impact
Level
  • Data interoperability challenges
  • Slow adoption of advanced analytics in countries with low healthcare IT maturity

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Expansion of national digital health strategies

A changing paradigm in European healthcare is the increasing alignment of regional healthcare infrastructures with broader national digital health strategies. These strategies are designed to modernize the delivery of healthcare and also optimize efficiency and data-driven decision-making. Germany and the Nordic countries are investing considerable amounts of time and money into designing and implementing national-level electronic health record systems and health data platforms. This establishes a firm foundation for a broader adoption of highly advanced analytics solutions in the healthcare space. As healthcare bodies and governments align with a national strategy, analytics solutions are becoming a crucial component in maximizing and transforming digital health infrastructures into real-world efficiencies and optimized outcomes.

Restraint: High upfront cost of advanced analytics platforms and cloud-based infrastructure

The healthcare sector of Europe still navigates continuous cost pressures since the providers and the public health systems operate within tightly controlled budgets. As advanced healthcare analytics, particularly those based on AI, large-scale data integration, and cloud infrastructure, demand substantial investment in upfront costs such as software licenses, IT modernization, data migration, and cybersecurity, for many hospitals and regional health authorities, especially in publicly funded systems, these initial costs of implementation either delay or limit their adoption despite longer-term efficiency gains. This holds true for smaller providers and fragmented networks of care, which slow market penetration in some areas of Europe for more sophisticated analytics solutions.

Opportunity: Push toward value-based care for outcome-based analytics

The European healthcare delivery models are also gradually migrating toward outcomes-based models of healthcare, focusing on patient outcomes, patient service quality, and cost-effectiveness, as opposed to the volume of services delivered. The EU initiatives and changes in the reimbursement models for healthcare are also encouraging stakeholders in the delivery of healthcare to track outcomes, streamline pathways of healthcare delivery, and measure the value delivered across the healthcare continuum. The migration of European healthcare toward outcomes-based models of healthcare delivery is also driving an increasing demand for outcomes-based healthcare analytics solutions across Europe.

Challenge: Data interoperability challenges

The adoption of care analytics in Europe is constrained by a fragmented mHealth ecosystem. The presence of multiple national EHR systems, data formats, and coding standards limits seamless data exchange across healthcare providers and countries. This fragmentation makes it challenging to aggregate longitudinal patient data and restricts cross-border analytics. As a result, healthcare organizations must spend a significant amount of time on data normalization, which delays the deployment and scalability of advanced AI-driven care analytics solutions in Europe.

EUROPE HEALTHCARE ANALYTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Claims-based healthcare analytics using Truven’s extensive MarketScan claims databases to identify cost drivers, utilization patterns, and treatment effectiveness across large populations Enables payers, providers, and life sciences organizations to optimize care pathways| Reduces unnecessary costs through data-backed insights on real-world utilization and outcomes
Fraud, Waste & Abuse (FWA) analytics using advanced machine learning and anomaly detection on claims data Reduces payer financial losses by accurately identifying inappropriate or fraudulent claims
Population health and risk management analytics using integrated clinical + claims datasets through Optum’s analytics platform Improves chronic disease management| Lowers medical cost by identifying high-risk members earlier
EHR-integrated clinical analytics powered by Oracle Cloud, providing real-time dashboards for hospital operations, quality, and clinical risk indicators Enhances clinical efficiency and operational performance through real-time, cloud-scalable insights
Real-world data analytics using Veradigm’s EHR network to support life sciences in drug safety, effectiveness, and market access studies Accelerates RWE generation for pharma| Reduces the time needed for regulatory and commercial decision support

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The Europe healthcare analytics market is made up of analytics solution providers such as Optum, Oracle, SAS, Veradigm, Merative, Health Catalyst, new entrants, specialized AI companies (Quibim, Owkin, Lucida Medical), infrastructure service providers (Microsoft Azure, AWS), and users (Karolinska University Hospital, University Hospital Zurich – USZ). The analytics vendors offer clinical intelligence, population health management, and value-based care platforms, and the AI-specialized companies offer high-end imaging analysis and RWE services. The infrastructure service providers offer agile and secure data processing and interoperability on the cloud. Users create demand for analytics to drive improved patient outcomes, operational efficiency, and alignment with regulation and reimbursement, making collaboration crucial for the innovation and growth of the European market.

europe-healthcare-analytics-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

europe-healthcare-analytics-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Europe Healthcare Analytics Market, By Component

As of 2024, the services segment showcased the largest market share in the Europe healthcare analytics market and will continue to lead through the end of 2025 due to the inherent complexities associated with the implementation of analytics. The services segment encompasses activities such as implementation, system integration, data migration, customization, training, and support. With respect to the adoption of EHR systems differing in each country, the need to adhere to strict data security policies, and the escalation in the usage of value-based care-related analytics solutions involving the aid of artificial intelligence, the dependence on specialized services to handle these factors will continue to maintain the leading market position of the services segment and the software solution segment in the market.

Europe Healthcare Analytics Market, By Type

In 2024, the descriptive analytics segment dominated the market for healthcare analytics in the European region by type and is expected to retain its dominance until the end of 2025. The healthcare industry and healthcare governing bodies continue to aggressively employ descriptive analytics to evaluate historical and current data sets for reporting and monitoring of healthcare delivery activities and the utilization of healthcare resources. The widespread use of dashboards, quality indicators, and population reports for healthcare continues to support informed healthcare decision-making for both healthcare delivery and administrative activities. The key role of descriptive analytics in enhancing healthcare transparency and healthcare accountability efforts in the European region continues to support its market dominance.

Europe Healthcare Analytics Market, By Application

As of 2024, clinical analytics is the leading application segment in the European market for healthcare analytics and is expected to retain this position through the end of 2025. The use of clinical analytics is also gaining momentum in hospitals and other healthcare organizations in Europe. Clinical analytics has applications in clinical decision support, care path optimization, outcome measurement, and monitoring. The establishment of nationwide electronic health records and the focus of European countries on patient safety and emerging models of value-based care are certain to place clinical analytics at the forefront of the European market for healthcare analytics.

Europe Healthcare Analytics Market, By End User

In 2024, the providers segment dominated the Europe healthcare analytics market, by end user. Due to direct accountability in clinical decisions, operational efficiency, and patient outcomes, C-suite executives top the list. Therefore, with the increasing burden of chronic diseases, growing cost pressures, and the widespread adoption of EHRs, investments in analytics for care optimization, resource management, and quality improvement have become a key focus area for hospitals and clinics.

REGION

Germany to be fastest-growing region in Europe healthcare analytics market during forecast period

The healthcare analytics market in Germany is expected to witness the fastest growth among all countries in Europe. This is due to the strong government support available for transforming the country's healthcare sector through digital means. The country has implemented various initiatives aimed at enhancing its electronic health records infrastructure. These have led to the increased adoption of advanced analytics in hospitals. Various sickness funds and healthcare providers have embraced analytics on the basis of clinical and outcome analytics. Germany has had one of the best health IT infrastructures and key analytics players. There is a growing focus on real-world evidence in the country.

europe-healthcare-analytics-market Region

EUROPE HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX

In the Europe healthcare analytics market matrix, Optum (Star) has a strong presence due to its comprehensive solution offerings, which leverage sophisticated analytics platforms for clinical intelligence, population health management, and value-based care. The scalable data integration offerings of Optum, combined with insights in artificial intelligence and their experience working with large healthcare systems, make them quite formidable in the market. Citius Health (Emerging Leader) will have a strong market impact as a result of analytic offerings focused on care coordination, data interoperability, and operational effectiveness. Although Optum retains the leading position due to its size, analytics acumen, and comprehensive capabilities, Citius Health certainly holds strong potential for moving into the leader position, driven by the growing need of European healthcare organizations for nimble analytics solutions.

europe-healthcare-analytics-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 14.17 BN
Market Forecast in 2030 (Value) USD 50.91 BN
CAGR 23.90%
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD BN)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Component:
    • Services
    • Software
  • By Type:
    • Descriptive Analytics
    • Predictive Analytics
    • Prescriptive Analytics
    • Diagnostic Analytics
  • By Application:
    • Financial Analytics
    • Clinical Analytics
    • Operational
    • Administrative Analytics
    • Population Health Analytics
  • By End User:
    • Payers
    • Providers
    • Pharmaceutical & Medical Device Supply Chain
Countries Covered Germany, UK, France, Italy, Spain, and Rest of Europe

WHAT IS IN IT FOR YOU: EUROPE HEALTHCARE ANALYTICS MARKET REPORT CONTENT GUIDE

europe-healthcare-analytics-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Competitive Landscape Mapping Profiling and market positioning of leading healthcare analytics vendors across clinical, population health, financial, and operational analytics, including AI-driven platforms, real-world evidence solutions, and cloud-based analytics services tailored for European healthcare systems
  • Enables benchmarking of analytics capabilities
  • Identifies differentiation across AI maturity and interoperability readiness
  • Supports vendor shortlisting
  • Informs partnership or acquisition strategies
Market Entry & Growth Strategy Country-level assessment of digital health maturity, analytics adoption drivers (e.g., national EHR programs, value-based care initiatives), reimbursement environments, and competitive intensity across Western and Northern Europe
  • Reduces market entry risk
  • Supports localization of analytics offerings
  • Accelerates adoption through alignment with national health priorities
  • Enables scalable expansion across fragmented European markets
Technology Adoption & Investment Trends
  • Analysis of adoption patterns for descriptive, predictive, and prescriptive analytics
  • Managed analytics services, cloud deployment models, and AI applications across clinical, population health, and value-based care use cases
  • Guides investment prioritization
  • Aligns analytics roadmaps with provider and payer needs
  • Supports outcome-driven technology selection
  • Enhances long-term return on digital health investments

RECENT DEVELOPMENTS

  • November 2025 : Siemens Healthineers (Germany) has outlined a new strategic focus on healthcare AI and digital innovation, with plans to accelerate cloud and AI capabilities that support remote diagnostics and telehealth integration as part of broader efforts to deliver personalized care across global markets, including Europe.
  • November 2025 : Veradigm (US) launched enhanced Ambient Scribe capabilities, an AI-powered solution designed to improve clinical documentation and support improved care delivery through advanced natural language capture and workflow tools, strengthening its digital health and virtual care technology stack. 
  • February 2025 : Koninklijke Philips N.V. (Netherlands) expanded its cloud-based radiology informatics services (Philips HealthSuite Imaging) across Europe, enabling secure, cloud-accessible diagnostic workflows and remote access to imaging and AI-enabled clinical tools that support telemedicine and virtual care delivery across multiple EU countries. 
  • COLUMN 'A' SHOULD BE IN TEXT FORMAT AND NOT DATE FORMAT :

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
4
MARKET OVERVIEW
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
4.2.4
CHALLENGES
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
5
INDUSTRY TRENDS
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
5.2.4
TRENDS IN EUROPE HEALTHCARE ANALYTICS INDUSTRY
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
5.5.1
INDICATIVE PRICING OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT, 2022–2025
 
 
 
 
5.5.2
INDICATIVE PRICING OF HEALTHCARE ANALYTICS SOLUTIONS, BY COUNTRY, 2022–2025
 
 
 
5.6
KEY CONFERENCES AND EVENTS, 2025–2027
 
 
 
 
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.8
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.9
CASE STUDY ANALYSIS
 
 
 
 
5.10
IMPACT OF 2025 US TARIFF – EUROPE HEALTHCARE ANALYTICS MARKET
 
 
 
 
 
 
5.10.2
INTRODUCTION
 
 
 
 
5.10.3
KEY TARIFF RATES
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.10.4
IMPACT ON COUNTRIES
 
 
 
 
 
5.10.4.1
GERMANY
 
 
 
 
5.10.4.2
UK
 
 
 
 
5.10.4.3
FRANCE
 
 
 
 
5.10.4.4
ITALY
 
 
 
 
5.10.4.5
SPAIN
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
6.3
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
6.5
FUTURE APPLICATIONS
 
 
 
 
6.6
IMPACT OF AI/GEN AI ON EUROPE HEALTHCARE ANALYTICS MARKET
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
6.6.2
BEST PRACTICES IN EUROPE HEALTHCARE ANALYTICS
 
 
 
 
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN EUROPE HEALTHCARE ANALYTICS
 
 
 
 
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN EUROPE HEALTHCARE ANALYTICS
 
 
7
REGULATORY LANDSCAPE
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
9
EUROPE HEALTHCARE ANALYTICS MARKET, BY COMPONENT (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
9.2
SERVICES
 
 
 
 
 
9.2.1
MANAGED SERVICES
 
 
 
 
 
9.2.1.1
ANALYTICAL SERVICES
 
 
 
 
9.2.1.2
CONSULTING SERVICES
 
 
 
9.2.2
PROFESSIONAL SERVICES
 
 
 
 
 
9.2.2.1
TRAINING & IMPLEMENTATION SERVICES
 
 
 
 
9.2.2.2
MAINTENANCE & SUPPORT SERVICES
 
 
9.3
SOFTWARE
 
 
 
 
 
9.3.1
ON-PREMISE SOFTWARE
 
 
 
 
9.3.2
CLOUD-BASED SOFTWARE
 
 
10
EUROPE HEALTHCARE ANALYTICS MARKET, BY TYPE (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
10.2
DESCRIPTIVE ANALYTICS
 
 
 
 
10.3
PREDICTIVE ANALYTICS
 
 
 
 
10.4
PRESCRIPTIVE ANALYTICS
 
 
 
 
10.5
DIAGNOSTIC ANALYTICS
 
 
 
11
EUROPE HEALTHCARE ANALYTICS MARKET, BY APPLICATION (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
11.2
FINANCIAL ANALYTICS
 
 
 
 
 
11.2.1
CLAIMS PROCESSING
 
 
 
 
11.2.2
REVENUE CYCLE MANAGEMENT
 
 
 
 
11.2.3
PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
 
 
 
 
11.2.4
RISK ADJUSTMENT & ASSESSMENT
 
 
 
11.3
CLINICAL ANALYTICS
 
 
 
 
 
11.3.1
QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
 
 
 
 
11.3.2
CLINICAL DECISION SUPPORT
 
 
 
 
11.3.3
REPORTING & COMPLIANCE
 
 
 
 
11.3.4
COMPARATIVE ANALYTICS/EFFECTIVENESS
 
 
 
 
11.3.5
PRECISION HEALTH/REAL-WORLD EVIDENCE
 
 
 
 
11.3.6
MEDICAL IMAGING ANALYTICS
 
 
 
11.4
OPERATIONAL & ADMINISTRATIVE ANALYTICS
 
 
 
 
 
11.4.1
SUPPLY CHAIN ANALYTICS
 
 
 
 
11.4.2
WORKFORCE ANALYTICS
 
 
 
 
11.4.3
STRATEGIC ANALYTICS
 
 
 
11.5
POPULATION HEALTH ANALYTICS
 
 
 
12
EUROPE HEALTHCARE ANALYTICS MARKET, BY END USER (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
12.2
PAYERS
 
 
 
 
 
12.2.1
PRIVATE INSURANCE COMPANIES
 
 
 
 
12.2.2
GOVERNMENT AGENCIES
 
 
 
12.3
PROVIDERS
 
 
 
 
 
12.3.1
HOSPITALS & CLINICS
 
 
 
 
12.3.2
POST-ACUTE CARE ORGANIZATIONS
 
 
 
 
12.3.3
AMBULATORY SURGERY CENTERS
 
 
 
 
12.3.4
OTHER PROVIDERS
 
 
 
12.4
PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
 
 
 
 
 
12.4.1
MANUFACTURERS
 
 
 
 
12.4.2
DISTRIBUTORS & WHOLESALERS
 
 
 
 
12.4.3
RETAILERS
 
 
13
EUROPE HEALTHCARE ANALYTICS MARKET, BY COUNTRY (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
13.4
EUROPE
 
 
 
 
 
13.4.1
GERMANY
 
 
 
 
13.4.2
UK
 
 
 
 
13.4.3
FRANCE
 
 
 
 
13.4.4
ITALY
 
 
 
 
13.4.5
SPAIN
 
 
 
 
13.4.6
REST OF EUROPE
 
 
14
COMPETITIVE LANDSCAPE
 
 
 
 
 
14.1
OVERVIEW
 
 
 
 
14.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
 
 
 
 
14.3
REVENUE ANALYSIS
 
 
 
 
 
14.4
MARKET SHARE ANALYSIS
 
 
 
 
 
14.5
BRAND COMPARISON
 
 
 
 
 
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
14.6.1
STARS
 
 
 
 
14.6.2
EMERGING LEADERS
 
 
 
 
14.6.3
PERVASIVE PLAYERS
 
 
 
 
14.6.4
PARTICIPANTS
 
 
 
 
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
14.6.5.1
COMPANY FOOTPRINT
 
 
 
 
14.6.5.2
COUNTRY FOOTPRINT
 
 
 
 
14.6.5.3
COMPONENT FOOTPRINT
 
 
 
 
14.6.5.4
APPLICATION FOOTPRINT
 
 
 
 
14.6.5.5
END-USER FOOTPRINT
 
 
14.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
14.7.1
PROGRESSIVE COMPANIES
 
 
 
 
14.7.2
RESPONSIVE COMPANIES
 
 
 
 
14.7.3
DYNAMIC COMPANIES
 
 
 
 
14.7.4
STARTING BLOCKS
 
 
 
 
14.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
14.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
14.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
14.9
COMPETITIVE SCENARIO
 
 
 
 
 
14.9.1
PRODUCT LAUNCHES
 
 
 
 
14.9.2
DEALS
 
 
 
 
14.9.3
EXPANSIONS
 
 
15
COMPANY PROFILES
 
 
 
 
 
15.1
KEY PLAYERS
 
 
 
 
 
15.1.1
MERATIVE
 
 
 
 
15.1.2
SAS INSTITUTE INC.
 
 
 
 
15.1.3
OPTUM, INC.
 
 
 
 
15.1.4
ORACLE
 
 
 
 
15.1.5
VERADIGM LLC
 
 
 
 
15.1.6
EXLSERVICE HOLDINGS, INC.
 
 
 
 
15.1.7
CITIUSTECH INC.
 
 
 
 
15.1.8
HEALTH CATALYST
 
 
 
 
15.1.9
CVS HEALTH
 
 
 
 
15.1.10
MCKESSON CORPORATION
 
 
 
 
15.1.11
COTIVITI, INC.
 
 
 
 
15.1.12
ENLITIC
 
 
 
 
15.1.13
IQVIA
 
 
 
 
15.1.14
WIPRO
 
 
 
 
15.1.15
KONINKLIJKE PHILIPS N.V
 
 
 
 
15.1.16
SIEMENS HEALTHINEERS
 
 
 
 
15.1.17
SOPHIA GENETICS
 
 
 
 
15.1.18
BC PLATFORMS
 
 
 
 
15.1.19
DATAVANT
 
 
 
 
15.1.20
SAVANA
 
 
 
15.2
OTHER PLAYERS
 
 
 
 
 
15.2.1
QUIBIM
 
 
 
 
15.2.2
OWKIN, INC
 
 
 
 
15.2.3
LUCIDA MEDICAL
 
 
 
 
15.2.4
TRANCEVERSE HEALTH
 
 
 
 
15.2.5
CEYLON GRAPHENE TECHNOLOGIES (PVT) LTD.
 
 
16
RESEARCH METHODOLOGY
 
 
 
 
 
16.1
RESEARCH DATA
 
 
 
 
 
16.1.1
SECONDARY DATA
 
 
 
 
 
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
16.1.2
PRIMARY DATA
 
 
 
 
 
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
16.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
16.1.2.4
KEY INDUSTRY INSIGHTS
 
 
16.2
MARKET SIZE ESTIMATION
 
 
 
 
 
16.2.1
BOTTOM-UP APPROACH
 
 
 
 
16.2.2
TOP-DOWN APPROACH
 
 
 
 
16.2.3
BASE NUMBER CALCULATION
 
 
 
16.3
MARKET FORECAST APPROACH
 
 
 
 
 
16.3.1
SUPPLY SIDE
 
 
 
 
16.3.2
DEMAND SIDE
 
 
 
16.4
DATA TRIANGULATION
 
 
 
 
16.5
FACTOR ANALYSIS
 
 
 
 
16.6
RESEARCH ASSUMPTIONS
 
 
 
 
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
17
APPENDIX
 
 
 
 
 
17.1
DISCUSSION GUIDE
 
 
 
 
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
17.3
CUSTOMIZATION OPTIONS
 
 
 
 
17.4
RELATED REPORTS
 
 
 
 
17.5
AUTHOR DETAILS
 
 
 

Methodology

The study involved five major activities to estimate the current size of the Europe Healthcare Analytics Market . Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of Europe Healthcare Analytics Market . It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global Europe Healthcare Analytics Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the Europe Healthcare Analytics Market . These methods were also used extensively to estimate the size of various subsegments in the market.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Europe Healthcare Analytics Market .

Market Definition

Healthcare analytics is the efficient use of data and related business insights developed through statistical, quantitative, predictive, comparative, diagnostics, and other emerging applied analytical models. These tools help reveal and understand historical data patterns, predict future outcomes, and provide actionable insights to drive fact-based decision-making for the improved clinical, financial, and operational performance of healthcare organizations.

Stakeholders

  • Stakeholders
  • Healthcare IT firms
  • Healthcare Analytics Vendors
  • Health Insurance Exchanges
  • Healthcare Payers
  • Healthcare Providers
  • Venture Capitalists
  • Research and Consulting Firms
  • Accountable Care Organizations (ACOs)

Report Objectives

  • To define, describe, and forecast the global Europe Healthcare Analytics Market based on component, type, application, end-user, and region.
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall Europe Healthcare Analytics Market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically analyze the market structure profile the key players of the Europe Healthcare Analytics Market and comprehensively analyze their core competencies.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To track and analyze competitive developments such as product launches and enhancements and investments, partnerships, collaborations, acquisitions, expansions, agreements, sales contracts, and alliances in the Europe Healthcare Analytics Market during the forecast period.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Europe Healthcare Analytics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Europe Healthcare Analytics Market

DMCA.com Protection Status